Alzamend Neuro, Inc. (ALZN)
NASDAQ: ALZN · IEX Real-Time Price · USD
0.400
+0.001 (0.23%)
Jun 20, 2024, 2:59 PM EDT - Market open

Alzamend Neuro Balance Sheet

Millions USD. Fiscal year is May - Apr.
Year
20232022202120202019
Cash & Equivalents
5.1414.061.930.090.04
Short-Term Investments
0000.10.21
Cash & Cash Equivalents
5.1414.061.930.190.25
Cash Growth
-63.45%628.97%909.03%-23.06%-
Other Current Assets
0.690.350.981.621.25
Total Current Assets
5.8414.412.911.811.5
Property, Plant & Equipment
0.080.1000
Total Long-Term Assets
0.080.1000
Total Assets
5.9214.522.911.811.5
Accounts Payable
2.871.160.560.991.18
Current Debt
000.3400
Total Current Liabilities
2.871.160.90.991.18
Total Liabilities
2.871.160.90.991.18
Total Debt
000.3400
Retained Earnings
-44.07-29.19-16.83-11.79-7.38
Shareholders' Equity
3.0513.352.010.820.32
Net Cash / Debt
5.1414.061.590.190.25
Net Cash / Debt Growth
-63.45%782.32%733.66%-23.06%-
Net Cash Per Share
0.792.370.330.040.06
Working Capital
2.9713.252.010.820.32
Book Value Per Share
0.472.250.420.170.08
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).